MARATTO

review · Narra X

Gender disparities in HIV infections: A narrative review of the persistent vulnerability of adolescent girls in Sub-Saharan Africa

Abstract

The human immunodeficiency virus (HIV) epidemic in Sub-Saharan Africa (SSA) disproportionately affects adolescent girls and young women (AGYW), who face a risk of infection up to three times higher than their male peers. SSA accounts for 65% of the global HIV burden, with Eastern and Southern Africa showing particularly high rates. The aim of this study was to examine the persistent gender disparities in HIV infections, focusing on the biological, social, and structural drivers of AGYW’s heightened vulnerability. Biological factors such as immature cervical development and hormonal influences intersect with social determinants, including gender inequality, cultural norms, and economic pressures. These factors reduce young women’s ability to negotiate safer sexual practices and increase reliance on transactional relationships with older partners. Despite initiatives such as determined, resilient, empowered, AIDS-free, mentored, and safe (DREAMS) and Education Plus, barriers such as stigma, gender-based violence, and limited access to youth-friendly sexual and reproductive health services persist. Addressing these disparities requires multi-level, gender-responsive interventions that strengthen healthcare access, expand female-controlled prevention options, and promote education and economic empowerment. Closing the gender gap in HIV outcomes will demand sustained policy commitment and community engagement tailored to the needs of adolescent girls in SSA.

Research topics

  • HIV/AIDS Impact and Responses
  • Adolescent Sexual and Reproductive Health

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.52225/narrax.v3i2.211

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.